1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Tylenol Relieves Pain For J&J Consumer As Baby Care Relaunch Loses Steam

 
• By Eileen Francis

Tylenol brand boosts J&J US OTC sales 8.4% to $477m, helping balance a 24.1% decline in baby care sales due to restocking reformulated Johnson’s Baby line in 2018, mostly in the US. Firm reports consumer health sales in the US were up 1.7% to $1.39bn.

Johnson's Baby mMoisture Wash, Shampoo. bath & Wash and Shampoo
J&J restaged Johnson’s baby care business in 2018 with products reformulated with more naturally derived ingredients and fewer ingredients overall.

US sales of Johnson & Johnson’s Tylenol OTC analgesic brand in its latest quarter helped offset a 24.1% plunge in its baby care division sales and drive its global consumer health sales up 1.7%.

The Tylenol line of multiple formulations containing acetaminophen was the “core” contributor to over-the-counter drug sales growth in the US, J&J reported on 15 October

More from Earnings

More from Business